Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter Schmid
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1–Selected Patients With NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Effects of Hiking at Moderate and Low Altitude on Cardiovascular Parameters in Male Patients With Metabolic Syndrome: Austrian Moderate Altitude Study
Wilderness and Environmental Medicine
Environmental
Public Health
Occupational Health
Sports Science
Emergency Medicine
Related publications
A Multicenter, Open Label, Uncontrolled, Phase Ii Trial Evaluating Safety and Efficacy of Venetoclax, Atezolizumab Andobinutuzumab in Richter Transformation From CLL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
NSCLC: Atezolizumab Mit Überlebensvorteil Unabhängig Vom PD-L1-Status
Pneumologie
Medicine
Pulmonary
Respiratory Medicine
Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study
Clinical Therapeutics
Pharmacology
P2.01-33 Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-Pd-(L)1 Containing Therapy (HUDSON)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Safety and Efficacy of Intrarenal Arterial Autologous CD34+ Cell Transfusion in Patients With Chronic Kidney Disease: A Randomized, Open-Label, Controlled Phase II Clinical Trial
Stem cells translational medicine
Medicine
Developmental Biology
Cell Biology
OA13 High-Dose Icotinib in Advanced NSCLC With EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-38 a Phase II With a Lead-In Phase I Study to Examine Safety and Efficacy of Hydroxychloroquine and Gefitinib in Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Efficacy and Safety of Obinutuzumab + Lenalidomide + Atezolizumab in Patients With Relapsed or Refractory Follicular Lymphoma: Primary Analysis of a Phase 1b/2 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
An Open Label Study to Evaluate Safety and Efficacy of Unex® Capsules in Patients With Urinary Disorders
Journal of Ayurveda Medical Sciences